RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 17 - per page Next page
Order by
CollaRx® & LiquiColl® Technologies
Collagen-based biodegradable matrices for localized drug delivery More
Plasmid DNA Vectors that Integrate into Host Chromosomal DNA in vivo: Stable Gene Transfer for Biological Studies and Gene Therapy
Plasmid DNA Vectors that Integrate into Host Chromosomal DNA in vivo: Stable Gene Transfer for Biological Studies and Gene Therapy More
Ultra-Fast Generation of Mice Expressing a Gene in a Specific (Haematopoietic) Cell Type of Interest
Ultra-Fast Generation of Mice Expressing a Gene in a Specific (Haematopoietic) Cell Type of Interest More
Adeno-Associated Virus (AAV) DNA Containing Helper Plasmids and Associated Technologies for AAV Production
Adeno-Associated Virus (AAV) DNA Containing Helper Plasmids and Associated Technologies for AAV Production More
In Vivo Production of Therapeutic Antibodies
In Vivo Production of Therapeutic Antibodies More
A Novel Vector for High Expression in Non-Dividing Haematopoietic Cells: A Hybrid Viral Vector for Transfer of Selected Genes
A Novel Vector for High Expression in Non-Dividing Haematopoietic Cells: A Hybrid Viral Vector for Transfer of Selected Genes More
New Peptide Nucleic Acids: Strong Binding to RNA and/or DNA
New Peptide Nucleic Acids: Strong Binding to RNA and/or DNA More
Robust Factor IX Minigene Expression Cassette: Gene Therapy for Inserting Genes that Require Liver-specific Expression
Robust Factor IX Minigene Expression Cassette: Gene Therapy for Inserting Genes that Require Liver-specific Expression More
High-titre Packaging Cell Lines Producing Retroviral Vectors in Suspension and Serum-Free Media
High-titre Packaging Cell Lines Producing Retroviral Vectors in Suspension and Serum-Free Media More
Production of SV40 Viral Vectors for Targeted Integration into Cells: Advancing Gene Therapy
Production of SV40 Viral Vectors for Targeted Integration into Cells: Advancing Gene Therapy More
Displaying 1..10 of 17 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Stakeholder Opinions: Gene Therapy - Gene therapy to deliver after 20 years of clinical development
Dec 2009 - 90 pages - $3,800
Gene Signal International SA. – Product Pipeline Review – Q1 2011
Mar 2011 - 34 pages - $500
Gene Express, Inc. - Product Pipeline Analysis
Mar 2011 - 24 pages - $750
Coldwell Banker Gene Armstrong, Inc. - Company Capsule
Nov 2011 - 6 pages - $75
Avir Green Hills Biotechnology AG – Product Pipeline Review – Q1 2011
Mar 2011 - 26 pages - $500
Pars Roos Biotechnology Co. - Product Pipeline Review - Q4 2010
Dec 2010 - 16 pages - $500
N-Gene Research Laboratories, Inc.-Detailed Product Pipeline
Jul 2010 - 20 pages - $750
Errant Gene Therapeutics, LLC-Detailed Product Pipeline
Jul 2010 - 19 pages - $750
Changchun ChangSheng Gene Pharmaceutical Co., Ltd.-Detailed Product Pipeline
Jul 2010 - 24 pages - $750
RNA therapy: the next big thing after monoclonal antibodies?
Oct 2008 - 80 pages - $7,600
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us